Elutia ELUT
NASDAQ ELUT
$0.95 +0.03 (+3.73%)
As of: Aug 21, 2026 · 3:59 PM EDT

Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026)

Elutia (ELUT) posted Liabilities and Shareholders Equity of $55.2 million for Q1 2026, down 11.45% sequentially from $62.4 million in Q4 2025, and up 40.49% YoY from $39.3 million in Q1 2025.

Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Elutia has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $55.2 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 40.49% year-over-year to $55.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180.8 million (up 9.1% YoY) and the FY2025 annual result came in at $62.4 million, up 72.59% from the prior year.
  • Liabilities and Shareholders Equity slipped to $55.2 million in Q1 2026 per ELUT's latest filing, from $62.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $68.8 million in Q4 2022 and troughed at $29.4 million in Q3 2025.
  • A 5-year average of $49.1 million and a median of $52.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity slumped 41.68% in 2024, then jumped 72.59% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $68.8 million in 2022, then sank by 36.92% to $43.4 million in 2023, then declined by 16.81% to $36.1 million in 2024, then surged by 72.59% to $62.4 million in 2025, then declined by 11.45% to $55.2 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $55.2 million, $62.4 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn 109.22 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 47.93 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 13.87 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 31.04 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 10.74 Bn
10 Elutia 40.75 Mn 20.85 Mn 1.45 Mn 43.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 55.21 Mn
Dec 31, 2025 62.35 Mn
Sep 30, 2025 29.41 Mn
Jun 30, 2025 33.85 Mn
Mar 31, 2025 39.30 Mn
Dec 31, 2024 36.13 Mn
Sep 30, 2024 48.41 Mn
Jun 30, 2024 41.90 Mn
Mar 31, 2024 35.36 Mn
Dec 31, 2023 43.43 Mn
Sep 30, 2023 54.58 Mn
Jun 30, 2023 52.33 Mn
Mar 31, 2023 60.63 Mn
Dec 31, 2022 68.84 Mn
Sep 30, 2022 61.02 Mn
Jun 30, 2022 52.85 Mn
Mar 31, 2022 59.93 Mn
Dec 31, 2021 67.17 Mn
Sep 30, 2021 59.90 Mn
Jun 30, 2021 69.70 Mn